Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Lei Qian and Hung Tseng.
Lei Qian
Connection Strength
6.814
Hung Tseng
  1. Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nat Commun. 2023 Jan 12; 14(1):189.
    View in: PubMed
    Score: 0.876
  2. Safety of tetanus, diphtheria, acellular pertussis (Tdap) vaccination during pregnancy. Vaccine. 2022 Jul 30; 40(32):4503-4512.
    View in: PubMed
    Score: 0.841
  3. Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nat Med. 2022 May; 28(5):1095.
    View in: PubMed
    Score: 0.834
  4. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nat Med. 2022 Feb 21.
    View in: PubMed
    Score: 0.823
  5. Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults. Clin Infect Dis. 2023 01 13; 76(2):252-262.
    View in: PubMed
    Score: 0.219
  6. A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccination. Vaccine. 2023 01 16; 41(3):844-854.
    View in: PubMed
    Score: 0.218
  7. Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies. Infect Dis Ther. 2023 Feb; 12(2):411-423.
    View in: PubMed
    Score: 0.218
  8. REPLY TO CHU. J Infect Dis. 2022 Jul 26.
    View in: PubMed
    Score: 0.212
  9. Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. PLoS One. 2022; 17(4):e0267824.
    View in: PubMed
    Score: 0.208
  10. Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination. Open Forum Infect Dis. 2022 Mar; 9(3):ofac011.
    View in: PubMed
    Score: 0.205
  11. Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults. J Infect Dis. 2021 Dec 28.
    View in: PubMed
    Score: 0.204
  12. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021 12 15; 375:e068848.
    View in: PubMed
    Score: 0.203
  13. Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study. Lancet Reg Health Am. 2022 Feb; 6:100134.
    View in: PubMed
    Score: 0.202
  14. Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older. Vaccine. 2021 02 05; 39(6):926-932.
    View in: PubMed
    Score: 0.191
  15. Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine. 2019 06 06; 37(26):3478-3484.
    View in: PubMed
    Score: 0.170
  16. Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus. Vaccine. 2019 Jan 03; 37(1):195-201.
    View in: PubMed
    Score: 0.160
  17. Pneumococcal Conjugate Vaccine Safety in Elderly Adults. Open Forum Infect Dis. 2018 Jun; 5(6):ofy100.
    View in: PubMed
    Score: 0.158
  18. Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization. BMC Health Serv Res. 2017 07 21; 17(1):503.
    View in: PubMed
    Score: 0.150
  19. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
    View in: PubMed
    Score: 0.125
  20. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83.
    View in: PubMed
    Score: 0.111
  21. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21.
    View in: PubMed
    Score: 0.109
  22. Confounder adjustment in vaccine safety studies: comparing three offset terms for case-centered approach. Vaccine. 2013 Jan 02; 31(2):431-5.
    View in: PubMed
    Score: 0.106
  23. Influenza vaccination and mortality among adults with heart failure in an integrated healthcare delivery system, 2009-2018. J Gen Intern Med. 2021 Aug 11.
    View in: PubMed
    Score: 0.050
  24. The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety Datalink. Pharmacoepidemiol Drug Saf. 2020 02; 29(2):182-188.
    View in: PubMed
    Score: 0.044
  25. The use of natural language processing to identify Tdap-related local reactions at five health care systems in the Vaccine Safety Datalink. Int J Med Inform. 2019 07; 127:27-34.
    View in: PubMed
    Score: 0.042
  26. Safety of Influenza Vaccination Administered During Hospitalization. Mayo Clin Proc. 2019 Mar; 94(3):397-407.
    View in: PubMed
    Score: 0.041
  27. Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
    View in: PubMed
    Score: 0.034
  28. Inpatient admission for febrile seizure and subsequent outcomes do not differ in children with vaccine-associated versus non-vaccine associated febrile seizures. Vaccine. 2014 Nov 12; 32(48):6408-14.
    View in: PubMed
    Score: 0.031
  29. Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort. Vaccine. 2014 May 07; 32(22):2574-81.
    View in: PubMed
    Score: 0.030

© 2024 Kaiser Permanente